Price movement over the last 24 hours
Abbott Laboratories vs iShares MSCI France ETF — how do they compare? Abbott Laboratories trades at $95.33 (market cap $166.94B), while iShares MSCI France ETF trades at $44.93. The key difference: Abbott Laboratories pays a 2.63% dividend while iShares MSCI France ETF pays none, and iShares MSCI France ETF is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | EWQ | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $136.62 | $48.35 |
52-Week Low | $82.57 | $41.43 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
EWQ trades at $46.07, up 0.33% today, with a bullish technical outlook from moving averages but neutral oscillators. Recent news highlights European equity strength and ECB rate hikes. Key support and resistance cluster at $46. A dividend of $1.09 is scheduled for June 2026.
Outlook is cautiously optimistic given technical momentum and European market tailwinds, but risks include geopolitical tensions and energy price volatility. The stock's performance is tied to broader European economic conditions and central bank policy shifts.
Trailing returns across standard periods
Latest headlines on both assets
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →EWQ is a country-specific ETF that tracks the performance of the French equity market. It provides exposure to major global brands across sectors like luxury goods, industrials, and healthcare, including LVMH, Schneider Electric, and Hermes.
Read more on EWQ →